Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
35 /100
MEDIUM RISK
Score updated Oct 13, 2026

TLSI — TriSalus Life Sciences, Inc. Dilution Risk Tracker

Track TLSI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TLSI — Get alerts when the score changes →

As of October 13, 2026, TriSalus Life Sciences, Inc. (TLSI) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. TriSalus Life Sciences, Inc. has a market capitalization of $254.92M, 61.57M shares outstanding, 85 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $40.00M, 7.40M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
10
📊 Float Risk
30
⚠️ Warrant Exposure
50
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 13%
💰 Capital Raise model 18%
• Active ATM program with $40M remaining capacity
📜 Warrant Exercise model 15%
• Warrant overhang: 12.0% of shares outstanding
🔔 Track TLSI — Get forecast alerts →

Market Data

Market Cap$254.92M
Shares Outstanding61.57M
Float49.24M
Cash$46.29M
Debt$33.06M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore35/100DilutionWatch score record
Shares Outstanding61.57MVerified float table or market cache
Public Float49.24MVerified float table or market cache
Market Cap$254.92MMarket data cache
Cash Runway24.6 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$40.00MSEC-derived dilution fields
Outstanding Warrants7.40MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 94.7% shares (2026Q1 vs prior)
85 institutional holders · 22.64M shares
#1 First Light Asset Management, LLC 5.07M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.69M shares
#3 AWM Investment Company, Inc. 2.08M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.35M
Days to Cover4.4
% of Float6.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-06
xbrl XBRL CONVERTIBLE 2025-05-30
4 INSIDER TRANSACTION 2026-04-01
4 INSIDER TRANSACTION 2026-03-20
4 INSIDER TRANSACTION 2026-03-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TLSI Dilution Snapshot

TriSalus Life Sciences, Inc. (TLSI) has a DilutionScore of 35/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TLSI's DilutionScore is currently 35/100 (Medium risk), with 2 score changes tracked over 89 days. The score improved from 32/100 (Medium risk).

Period Score Risk Level Duration
Sep 28 – Oct 13, 202635/100MEDIUM16 days
Aug 22 – Sep 27, 202632/100MEDIUM37 days
Jul 16 – Aug 21, 202630/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TLSI shares outstanding have increased 2.7% from 59.81M (Mar 2026) to 61.42M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202661.42M49.24M▲ 0.50%
May 27, 202661.42M48.99M▼ 0.93%
May 23, 202661.42M49.45M▼ 4.04%
May 21, 202661.42M51.54M▼ 0.12%
May 14, 202661.42M51.60M▲ 0.18%
Apr 13, 202661.41M51.51M▼ 0.66%
Apr 07, 202661.41M51.85M▲ 0.03%
Mar 28, 202661.31M51.83M▲ 0.03%
Mar 09, 202659.81M51.81M▲ 0.46%
Mar 07, 202659.81M51.58M▲ 22.70%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TLSI Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TLSI files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TLSI — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TLSI
TLSI FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.